Seoul, South Korea

Dongsik Kim


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dongsik Kim: Innovator in Pharmaceutical Treatments

Introduction

Dongsik Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments utilizing anti-c-Met antibodies. His innovative work aims to address various diseases through targeted therapies.

Latest Patents

Dongsik Kim holds 1 patent for his invention titled "Methods of treatment using anti-c-met antibodies." This patent describes a pharmaceutical composition designed to prevent or treat a variety of diseases by activating c-Met in cells through the use of the anti-c-Met antibody, which functions as a c-Met agonist. The invention highlights a method for leveraging c-Met activation to combat various health conditions effectively.

Career Highlights

Throughout his career, Dongsik Kim has been associated with Helixmith Co., Ltd., a company focused on innovative biopharmaceutical solutions. His work at Helixmith has positioned him as a key player in the development of advanced therapeutic strategies.

Collaborations

Dongsik Kim has collaborated with notable colleagues, including Seung Shin Yu and Jae-Gyun Jeong. These partnerships have contributed to the advancement of research and development in the pharmaceutical sector.

Conclusion

Dongsik Kim's contributions to the field of pharmaceuticals through his innovative patent demonstrate his commitment to improving healthcare solutions. His work continues to inspire advancements in treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…